The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1413
ISSUE 1413
April 1, 2013
Issue 1413
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Two New Drugs for Homozygous Familial Hypercholesterolemia
April 1, 2013 (Issue: 1413)
The FDA has approved mipomersen (Kynamro –
Genzyme) and lomitapide (Juxtapid – Aegerion), each
in addition to a low-fat diet and other lipid-lowering medications,
to reduce cholesterol levels in patients with
homozygous familial...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.